LegoChem Biosciences, Inc. (141080.KQ)
KRW 96700.0
(-6.84%)
KRW 96700.0
(-6.84%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 34.14 Billion | 33.41 Billion | 32.15 Billion | 49.39 Billion | 57.5 Billion | 25.24 Billion |
| Cost of Revenue | 16.34 Billion | 17.57 Billion | 16.35 Billion | 15.9 Billion | 24.84 Billion | 20.85 Billion |
| Gross Profit | 17.79 Billion | 15.83 Billion | 15.8 Billion | 33.49 Billion | 32.65 Billion | 4.38 Billion |
| Operating Expenses | 98.61 Billion | 70.87 Billion | 52.33 Billion | 65.19 Billion | 26.25 Billion | 23.09 Billion |
| Selling, General and Administrative Expenses | 16.5 Billion | 15.15 Billion | 4.44 Billion | 9.05 Billion | 7.52 Billion | 4.85 Billion |
| Research and Development Expenses | 79.6 Billion | 55.71 Billion | 47.89 Billion | 56.14 Billion | 18.52 Billion | 18.23 Billion |
| Other Expenses | 2.5 Billion | 442.45 Million | 3.13 Billion | -3.72 Million | -204.87 Million | -285 Thousand |
| Cost and Expenses | 114.96 Billion | 88.44 Billion | 68.68 Billion | 81.09 Billion | 51.1 Billion | 43.94 Billion |
| Operating Income | -80.82 Billion | -55.03 Billion | -36.53 Billion | -31.7 Billion | 6.39 Billion | -18.7 Billion |
| Interest Expense | 528.26 Million | 285.75 Million | 68.76 Million | -1200.00 | 25.8 Million | 125.74 Million |
| Income Tax Expense | -2.04 Billion | -2.63 Billion | 2.86 Billion | -1.84 Billion | 626.01 Million | -354.09 Million |
| Earnings before Tax | -75.74 Billion | -47.77 Billion | -20.64 Billion | -10.57 Billion | 13.1 Billion | -26.42 Billion |
| Net Income | -73.7 Billion | -45.09 Billion | -23.39 Billion | -6.98 Billion | 13.58 Billion | -25.77 Billion |
| Earnings Per Share Basic | -2595.00 | -1850.84 | -969.59 | -307.05 | 640.57 | -1222.79 |
| Earnings Per Share Diluted | -2594.83 | -1850.84 | -969.59 | -307.05 | 565.81 | -1222.79 |
| Weighted Average Shares Outstanding | 28.4 Million | 24.36 Million | 24.12 Million | 22.75 Million | 21.2 Million | 21.07 Million |
| Weighted Average Shares Outstanding (Diluted) | 28.4 Million | 24.36 Million | 24.12 Million | 22.75 Million | 24.01 Million | 21.07 Million |
| Gross Margin | 0.52 | 0.47 | 0.49 | 0.68 | 0.57 | 0.17 |
| EBIT Margin | -2.09 | -1.52 | -1.04 | -0.58 | 0.18 | -0.63 |
| Profit Margin | -2.16 | -1.35 | -0.73 | -0.14 | 0.24 | -1.02 |
| EBITDA | -71.38 Billion | -43.37 Billion | -17.52 Billion | -26.76 Billion | 16.98 Billion | -23.52 Billion |
| Earnings Before Tax Margin | -2.37 | -1.65 | -1.14 | -0.64 | 0.11 | -0.74 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 30.75 Billion | 31.05 Billion | 9.18 Billion | 34.14 Billion | 5.21 Billion | 12.08 Billion |
| Cost of Revenue | 4.87 Billion | 4.35 Billion | 4.79 Billion | 18.54 Billion | 4.38 Billion | 4.49 Billion |
| Gross Profit | 25.87 Billion | 26.69 Billion | 4.38 Billion | 15.6 Billion | 830.98 Million | 7.58 Billion |
| Operating Expenses | 36.48 Billion | 23.83 Billion | 30.32 Billion | 97.19 Billion | 21.27 Billion | 24.54 Billion |
| Selling, General and Administrative Expenses | 5.19 Billion | 5.11 Billion | 2.93 Billion | - | 8.44 Billion | 2.88 Billion |
| Research and Development Expenses | 31.28 Billion | 18.72 Billion | 27.39 Billion | - | 12.82 Billion | 21.65 Billion |
| Other Expenses | -37.14 Billion | 7.54 Million | 189.54 Million | 284.08 Million | 49.01 Million | 38.08 Million |
| Cost and Expenses | 41.35 Billion | 28.19 Billion | 35.12 Billion | 115.74 Billion | 25.65 Billion | 29.03 Billion |
| Operating Income | -10.6 Billion | 2.86 Billion | -25.94 Billion | -81.59 Billion | -20.44 Billion | -16.95 Billion |
| Interest Expense | 145.71 Million | 146.44 Million | 145.46 Million | 528.26 Million | - | - |
| Income Tax Expense | 123.24 Million | 326.93 Million | -2.04 Billion | -2.04 Billion | 16.72 Thousand | 4.04 Million |
| Earnings before Tax | -7.87 Billion | 9.66 Billion | -18.79 Billion | -76.58 Billion | -19.85 Billion | -20.15 Billion |
| Net Income | -7.44 Billion | 9.41 Billion | -16.15 Billion | -73.7 Billion | -19.76 Billion | -20.04 Billion |
| Earnings Per Share Basic | -204.39 | 329.68 | -577.25 | - | -749.25 | -756.54 |
| Earnings Per Share Diluted | -204.39 | 328.05 | -577.25 | - | -749.25 | -756.54 |
| Weighted Average Shares Outstanding | 36.42 Million | 28.55 Million | 27.98 Million | 28.4 Million | 26.37 Million | 26.48 Million |
| Weighted Average Shares Outstanding (Diluted) | 36.42 Million | 28.69 Million | 27.98 Million | 28.4 Million | 26.37 Million | 26.48 Million |
| Gross Margin | 0.84 | 0.86 | 0.48 | 0.46 | 0.16 | 0.63 |
| EBIT Margin | -0.30 | 0.13 | -2.69 | - | -3.69 | -1.31 |
| Profit Margin | -0.24 | 0.30 | -1.76 | -2.16 | -3.79 | -1.66 |
| EBITDA | -9.35 Billion | 4.06 Billion | -24.71 Billion | - | -19.27 Billion | -15.79 Billion |
| Earnings Before Tax Margin | -0.34 | 0.09 | -2.82 | -2.39 | -3.92 | -1.40 |
HTZWW
034300
TTLTF
603600
DZRD
605199